-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexeo Therapeutics Q2 EPS $(0.30) Misses $(0.28) Estimate

Benzinga·08/12/2026 11:08:09
Listen to the news
Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 50 percent increase over losses of $(0.60) per share from the same period last year.